-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
At present, in order to strengthen drug quality supervision and ensure the safety of drug use by the public, many places have launched supervision and inspection of drug production, operation, and use units, and issued relevant drug quality announcements, and adopted control measures for unqualified drugs in random inspections and investigated and dealt with in accordance with the law.
.
For example, recently, the Hubei Provincial Food and Drug Administration issued a notice of administrative punishment.
Hubei Jinlong Pharmaceutical Co.
, Ltd.
was found during unannounced inspections that the company was punished for using Chinese medicinal materials that did not meet the requirements of the Chinese Pharmacopoeia
.
Specifically, the company used non-compliant Chinese medicinal materials to produce Jianersu granule extracts.
Currently, the company has confiscated 700Kg of Chinese medicinal materials Codonopsis (batch number 2011073) and 234Kg of myrobalan (batch number 210115); and has been fined.
.
Prior to this, the Sanming Drug Inspection Office of the Fujian Provincial Drug Administration also announced an administrative penalty information disclosure form.
A pharmaceutical company was fined 30,000 for producing and selling inferior drugs! According to the administrative penalty decision, the type of administrative punishment for a pharmaceutical company in Fujian for the production and sale of inferior drugs such as Baixian Pi, Qianhu, and Epimedium and according to relevant regulations, the Office decided to impose the following penalties on the parties: The Office ordered the parties immediately Corrected illegal activities, confiscated 2 kilograms of inferior medicine Qianhu, 12.
5 kilograms of Sun Epimedium; confiscated the illegal income of 9026.
1 yuan; imposed 2.
1 times the value of 11,707 yuan in the illegal production and sale of the inferior drugs Baixian Hu, Qian Hu, and Sun Epimedium The fine was 2,4584.
7 yuan
.
The above fines and confiscated amounts totaled 33610.
8 yuan
.
In addition to the above announcements, in fact, since the beginning of this year, there have been many cases in which provincial drug regulatory bureaus have been punished and warned for producing and selling counterfeit and inferior drugs
.
Judging from the actions of local punishments, they mainly include ordering corrections, warnings, the prohibition of relevant legal representatives from engaging in drug production and business activities, and imposing fines, which amount to hundreds of thousands of yuan or even more than one million
.
For pharmaceutical companies that illegally produce and sell inferior drugs, it can be said that the gains outweigh the gains
.
In fact, traditional Chinese medicinal materials have always been difficult to preserve and other problems, and there are also problems in the production process and quality control
.
Therefore, in response to the traditional processing, counterfeiting, selling, and irregular processing of Chinese herbal medicines, the state has issued a series of corresponding policies and regulations in recent years.
.
What is worth mentioning is the implementation of the new version of the Pharmacopoeia at the end of 2020.
The document also clearly pointed out that the concept of medicine refers to the prevention, treatment, and diagnosis of human diseases, purposeful regulation of human physiological functions, and provisions for indications or Substances with functions, indications, usage and dosage, including traditional Chinese medicine, chemical medicine and biological products
.
The document clearly prohibits the production (including preparation, the same below), the sale, and the use of counterfeit and inferior drugs
.
In this context, the industry believes that Chinese medicine companies need to strictly check all aspects, adjust production and operation strategies in a timely manner, and improve product quality, otherwise they will face high illegal costs and even be eliminated
.
But at the same time, the industry also stated that through continuous supervision, random inspection, investigation, and rectification of drugs, the quality of drugs will be well guaranteed, and the safety of patients' medication will also be further guaranteed
.
.
For example, recently, the Hubei Provincial Food and Drug Administration issued a notice of administrative punishment.
Hubei Jinlong Pharmaceutical Co.
, Ltd.
was found during unannounced inspections that the company was punished for using Chinese medicinal materials that did not meet the requirements of the Chinese Pharmacopoeia
.
Specifically, the company used non-compliant Chinese medicinal materials to produce Jianersu granule extracts.
Currently, the company has confiscated 700Kg of Chinese medicinal materials Codonopsis (batch number 2011073) and 234Kg of myrobalan (batch number 210115); and has been fined.
.
Prior to this, the Sanming Drug Inspection Office of the Fujian Provincial Drug Administration also announced an administrative penalty information disclosure form.
A pharmaceutical company was fined 30,000 for producing and selling inferior drugs! According to the administrative penalty decision, the type of administrative punishment for a pharmaceutical company in Fujian for the production and sale of inferior drugs such as Baixian Pi, Qianhu, and Epimedium and according to relevant regulations, the Office decided to impose the following penalties on the parties: The Office ordered the parties immediately Corrected illegal activities, confiscated 2 kilograms of inferior medicine Qianhu, 12.
5 kilograms of Sun Epimedium; confiscated the illegal income of 9026.
1 yuan; imposed 2.
1 times the value of 11,707 yuan in the illegal production and sale of the inferior drugs Baixian Hu, Qian Hu, and Sun Epimedium The fine was 2,4584.
7 yuan
.
The above fines and confiscated amounts totaled 33610.
8 yuan
.
In addition to the above announcements, in fact, since the beginning of this year, there have been many cases in which provincial drug regulatory bureaus have been punished and warned for producing and selling counterfeit and inferior drugs
.
Judging from the actions of local punishments, they mainly include ordering corrections, warnings, the prohibition of relevant legal representatives from engaging in drug production and business activities, and imposing fines, which amount to hundreds of thousands of yuan or even more than one million
.
For pharmaceutical companies that illegally produce and sell inferior drugs, it can be said that the gains outweigh the gains
.
In fact, traditional Chinese medicinal materials have always been difficult to preserve and other problems, and there are also problems in the production process and quality control
.
Therefore, in response to the traditional processing, counterfeiting, selling, and irregular processing of Chinese herbal medicines, the state has issued a series of corresponding policies and regulations in recent years.
.
What is worth mentioning is the implementation of the new version of the Pharmacopoeia at the end of 2020.
The document also clearly pointed out that the concept of medicine refers to the prevention, treatment, and diagnosis of human diseases, purposeful regulation of human physiological functions, and provisions for indications or Substances with functions, indications, usage and dosage, including traditional Chinese medicine, chemical medicine and biological products
.
The document clearly prohibits the production (including preparation, the same below), the sale, and the use of counterfeit and inferior drugs
.
In this context, the industry believes that Chinese medicine companies need to strictly check all aspects, adjust production and operation strategies in a timely manner, and improve product quality, otherwise they will face high illegal costs and even be eliminated
.
But at the same time, the industry also stated that through continuous supervision, random inspection, investigation, and rectification of drugs, the quality of drugs will be well guaranteed, and the safety of patients' medication will also be further guaranteed
.
